Fengmin Zhao Selected Research

Adenocarcinoma

1/2020

Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fengmin Zhao Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 03/2012
17	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2012
8	Melanoma (Melanoma, Malignant) 09/2017 - 01/2013
7	Fatigue 01/2022 - 02/2014
3	Triple Negative Breast Neoplasms 01/2024 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2020
2	Lymphoma (Lymphomas) 10/2022 - 01/2020
2	Disease Progression 01/2022 - 01/2018
2	Pain (Aches) 01/2022 - 02/2014
2	Diarrhea 01/2020 - 01/2018
2	Obesity 07/2015 - 12/2012
1	Multiple Myeloma 03/2024
1	Lymphedema (Milroy Disease) 12/2021
1	Residual Neoplasm 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020
1	Adenocarcinoma 01/2020
1	Leukopenia 01/2020
1	Neutropenia 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Stomatitis 01/2018
1	Hypertriglyceridemia 01/2018
1	Exanthema (Rash) 01/2018
1	Hyperglycemia 01/2018
1	Anemia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 03/2017
1	Carcinoma (Carcinomatosis) 03/2017

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 01/2023 - 03/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 09/2012
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 07/2015
5	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2013
4	Aromatase InhibitorsIBA 10/2021 - 01/2018
4	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 01/2013
4	taxaneIBA 11/2015 - 09/2012
3	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 03/2017
3	exemestane (Aromasin)FDA Link 10/2021 - 01/2018
3	Peptides (Polypeptides)IBA 09/2017 - 08/2013
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 08/2013
2	PlatinumIBA 01/2024 - 10/2021
2	Capecitabine (Xeloda)FDA Link 01/2024 - 10/2021
2	Indicators and Reagents (Reagents)IBA 07/2023 - 12/2022
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2020
2	Histone Deacetylase InhibitorsIBA 10/2021 - 01/2018
2	entinostat (MS 275)IBA 10/2021 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	CytokinesIBA 01/2017 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 09/2012
2	Docetaxel (Taxotere)FDA Link 07/2015 - 09/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015 - 09/2012
1	carfilzomibIBA 03/2024
1	Lenalidomide (CC 5013)FDA Link 03/2024
1	Bortezomib (Velcade)FDA Link 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024
1	copanlisibIBA 10/2022
1	human ERBB2 proteinIBA 10/2021
1	Aurora Kinase AIBA 01/2021
1	veliparibIBA 10/2020
1	Etoposide (VP 16)FDA LinkGeneric 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	trametinibIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Vorinostat FDA Link 09/2017
1	Monatide (IMS 3015)IBA 09/2017
1	Protein Subunit VaccinesIBA 09/2017
1	AntigensIBA 09/2017
1	Trastuzumab (Herceptin)FDA Link 09/2017
1	Cetuximab (Erbitux)FDA Link 03/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	LigandsIBA 01/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2017
1	AutoantigensIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	InterferonsIBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017

Therapy/Procedure

27	Therapeutics 03/2024 - 03/2012
7	Drug Therapy (Chemotherapy) 02/2023 - 03/2012
3	Radiotherapy 01/2022 - 03/2017
2	Neoadjuvant Therapy 10/2021 - 01/2020
1	Colostomy 01/2020
1	Secondary Prevention 01/2020
1	Aftercare (After-Treatment) 09/2017
1	Chemoradiotherapy 03/2017